US 9091696
Modulation of NR2F6 and methods and uses thereof
granted A61KA61K31/00A61K31/7088
Quick answer
US patent 9091696 (Modulation of NR2F6 and methods and uses thereof) held by Regen Biopharma, Inc. expires Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Regen Biopharma, Inc.
- Grant date
- Tue Jul 28 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 23 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K31/00, A61K31/7088